References
Ahlfors UG, Baastrup PC, Denckler SJ, Eigen K, Linjaerde O, et al. Flupenthixol decanoate in recurrent manic depressive illness: a comparison with lithium. Acta Psychiatrica Scandinavica 64: 226–237, 1986
Akiskal HS. A proposed clinical approach to chronic and ‘resistant’ depressions: evaluation and treatment. Journal of Clinical Psychiatry 46: 32–36, 1985
Angst J. Switch from depression to mania, and from mania to depression: role of psychotropic drugs. Psychopharmacology Bulletin 23: 66–67, 1987
Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. American Journal of Psychiatry 137: 782–790, 1980
Barton BM, Gitin MJ. Verapamil in treatment-resistant mania: an open trial. Journal of Clinical Psychopharmacology 7: 101–103, 1987
Black DW, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. Journal of Clinical Psychiatry 48: 132–139, 1987
Brennan MJW, Sandyk R, Borsock D. Use of sodium valproate in the management of affective disorders — basic and clinical aspects. In Emrich et al. (Eds) Anticonvulsants in affective disorders, pp. 14–32, Excerpta Medica, Amsterdam, 1984
Brotman AW, Farhadi AM, Gelenberg AJ. Verapamil treatment of acute mania. Journal of Clinical Psychiatry 47: 136–138, 1986
Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biological Psychiatry 18: 451–486, 1983
Coppen A, Ghose K, Rao R. Mianserin and lithium in the prophylaxis of depression. British Journal of Psychiatry 133: 206–210, 1978
Coppen A, Montgomery SA, Gupta RK, Bailey JE. A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. British Journal of Psychiatry 128: 479–485, 1976
Davidson J, Raft D. The use of phenelzine in continuation therapy. Neuropsychobiology 11: 191–194, 1984
de Montigny C, Cournoyer G, Morissette R, Langlois R, Caille G. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Archives of General Psychiatry 40: 1327–1334, 1983
de Montigny C, Grunberg F, Mayer A, Deschenes J-P. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. British Journal of Psychiatry 138: 252–256, 1981
Dubovsky SL, Franks RD, Lifschitz ML, Coen P. Effectiveness of verapamil in the treatment of a manic patient. American Journal of Psychiatry 135: 502–504, 1982
Emrich HM, Dose M, von Zerssen D. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorder. Journal of Affective Disorders 8: 243–250, 1985
Emrich HM, von Zerssen D, Kissling W, Moller H-J, Windorfer A. Effect of sodium valproate on mania: the GABA-hypothesis of affective disorders. Archives of Psychiatry 229: 1–6, 1980
Esparon J, Kalloori J, Naylor GJ, Mettarg AM, Smith AHW, et al. Comparison of the prophylactic action of flupenthixol with placebo in lithium — treated manic-depressive patients. British Journal of Psychiatry 148: 723–725, 1986
Giannini AJ, Houser WL, Loiselle RH, Giannini MC, Price WA. Antimanic effects of verapamil. American Journal of Psychiatry 141: 1602–1603, 1984
Giannini AJ, Loiselle RH, Price WA, Giannini MC. Comparison of antimanic efficacy of clonidine and verapamil. Clinical Journal of Pharmacology 25: 307–308, 1985
Giannini AJ, Pascarzi GA, Loiselle RH, Price WA, Giannini MC. Lithium in the treatment of mania. American Journal of Psychiatry 143: 1608–1609, 1986
Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N. Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders 13: 267–272, 1987
Glen A, Johnson AL, Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind trial. Psychological Medicine 14: 37–50, 1984
Goodwin FK, Prange AJ, Post RM, Muscettola S, Lipton MA. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-responders. American Journal of Psychiatry 139: 34–38, 1982
Heninger GR, Charney DS, Sternberg DF. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Archives of General Psychiatry 40: 1335–1342, 1983
Himmelhoch JM, Detre T, Kupfer DJ, Swartzburg M, Byck R. Treatment of previously intractable depressions with tranylcypromine and lithium. Journal of Nervous and Mental Disorders 155: 216–220, 1972
Hopkinson G, Kenny F. Treatment with reserpine of patients resistant to tricyclic antidepressants. Psychiatry Clinics 8: 109–114, 1975
Kane JM, Quitkin FH, Rifkin A, Ramos-Lorenzi JR, Nayak DD, et al. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. Archives of General Psychiatry 39: 1065–1069, 1982
Katon W, Raskind M. Treatment of depression in the medically ill elderly with methylphenidite. American Journal of Psychiatry 137: 963–965, 1980
Kay DWK, Fahy T, Garside RF. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated patients. British Journal of Psychiatry 117: 667–671, 1970
Lerer B, Moore N, Mayendorff E, Cho S-R, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. Journal of Clinical Psychiatry 48: 89–93, 1987
Lewis J, Winokur G. The introduction of mania: a natural history study with controls. Archives of General Psychiatry 39: 303–306, 1982
McElroy SL, Keck Jr PE, Pope Jr GH. Sodium valproate: its use in primary psychotic disorders. Journal of Clinical Psychopharmacology 7: 16–24, 1987
Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychological Medicine 3: 5–17, 1973
Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepam for the management of manic agitation. Journal of Clinical Psychopharmacology 5: 109–113, 1985
Moscovich D, Mester R. Tricyclic antidepressive treatment reinforced by reserpine. Israeli Journal of Psychiatry and Related Sciences 21: 283–289, 1984
Naylor GL, Martin B, Hopwood SE, Watson Y. A two year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biological Psychiatry 21: 915–920, 1986
Nolen WA. Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatrica Scandinavica 67: 218–225, 1983
O’Flanagan PM. Clomipramine confusion and lithium carbonate a synergistic effect? Lancet 2: 974, 1973
Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A, et al. Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatrica and Neurologica Japonica 27: 283–297, 1973
Pai M, White AC, Deane AH. Lithium augmentation in the treatment of delusional depression. British Journal of Psychiatry 148: 736–738, 1986
Poldinger W. Combined administration of desipramine and reserpine or tetrabenazine in depressive patients. Psychopharmacologia 4: 308–310, 1963
Post RM, Uhde TW. Treatment of mood disorders with anti-epileptic medications: clinical and theoretical implications. Epilepsia 24: S97–S108, 1983
Prange AJ, Wilson IC, Rabon AM, Lipton MA. Enhancement of imipramine antidepressant activity by thyroid hormone. American Journal of Psychiatry 126: S97–S108, 1970
Price LH, Charney DS, Heninger GR. Efficacy of lithium-tranylcypromine treatment in refractory depression. American Journal of Psychiatry 142: 619–623, 1985
Prien RF, Klett CJ, Caffey Jr EM. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Archives of General Psychiatry 29: 420–425, 1973
Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? American Journal of Psychiatry 143: 18–23, 1986
Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Archives of General Psychiatry 41: 1096–1104, 1984
Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar patients: a double-blind study. Archives of General Psychiatry 38: 902–907, 1981
Seager CP, Bird RL. Imipramine with electrical treatment in depression — a controlled trial. Journal of Mental Science 108: 704–707, 1962
Shaw DM. Pharmacologic treatment of hypomania and mania. Psychiatric Annals 17: 316–323, 1987
Shaw DM. Pharmacological management of treatment-resistant depression. In Casey et al. (Eds) Current trends in psychopharmacology, pp. 118–129, Springer-Verlag, Heidelberg, 1988
Shaw DM, MacSweeney DA, Hewland R, Johnson L. Tricyclics and tryptophan in unipolar depression. British Journal of Psychiatry 130: 432–451, 1975
Strömgren L, Boller S. Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Psychiatric Developments 4: 349–367, 1985
Tyrer P. Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long-term treatment. Journal of Affective Disorders 6: 1–7, 1984
Wålinder J, Skoff A, Carlsson A, Nagy A, Roos B-E. Potentiation of the antidepressant action of clomipramine by tryptophan. Archives of General Psychiatry 33: 1384–1389, 1976
Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM. The effect of carbamazepine and lithium on remission from affective illness. British Journal of Psychiatry 150: 180–182, 1987
Wehr TA, Goodwin FK. Do antidepressants cause mania? Psychopharmacological Bulletin 23: 61–65, 1987
Zubenko GS, Cohen BM, Lipinski JF, Jonas JM. Clonidine in the treatment of mania and mixed bipolar disorder. American Journal of Psychiatry 141: 1617–1618, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shaw, D.M. Drug Alternatives to Lithium in Manic-Depressive Disorders. Drugs 36, 249–255 (1988). https://doi.org/10.2165/00003495-198836030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198836030-00001